You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨 AI醫療爆發助力中康控股(2361.HK)反彈 8個交易日區間最大升幅逼近翻倍
格隆匯 02-13 17:33
中康控股(2361.HK)午後拉昇,盤中一度大升超26%至4.3港元,2月4日盤中觸及月內低點2.24港元后強勢反彈,迄今僅僅8個交易日,區間最大升幅高達92%,遠遠跑贏大盤表現。消息面上,中康控股旗下主要業務平台中康科技2月6日成功接入“DeepSeek大模型”,並與自主研發的“卓睦鳥醫療大模型”融合,助力AI醫療加速落地,市場潛力可期。此外,中康控股在AI醫療領域、健康管理領域的佈局成果顯著,其構建的“天宮一號”商用數據智能中台和“卓睦鳥”智慧健康管理與醫療中台,實現了從數據採集、處理到應用的全鏈條數字化服務。中康科技自主研發的醫療垂類大模型“卓睦鳥醫療大模型”在2024年12月的國內醫療大模型測評平台CMB發佈的榜單中,以97.09的綜合平均分榮獲第一。中康控股在大數據處理、AI技術應用以及智慧健康管理等方面也有長期的積累和深度的佈局,其業務涵蓋了TO B、TO C、TO R等多個領域,形成了較為完整的產業鏈條,AI更是貫穿其業務的各個環節,全面賦能公司的發展。有女版巴菲特之稱的“木頭姐”曾指出,醫療行業目前佔據了驚人的存儲量,而數據就是關鍵,醫療保健是最被低估的AI應用領域。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account